Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test

September 14, 2021 sandiegobiotech News Comments Off on Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test

SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth factor.

Click here to view original post

Related Articles

No Picture
News

Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

August 19, 2021 sandiegobiotech News Comments Off on Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to 40,000,000 shares of its common stock. Each share… Click here to view original post… […]

No Picture
News

Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update

August 5, 2021 sandiegobiotech News Comments Off on Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report second quarter 2021 financial results on Thursday, August 12, 2021 after the close of financial markets. Progenity’s management will host a webcast and conference call at 4:30… Click here to view original post… […]